1. HOME
2. Research Insight
3. BASF SE (Germany), FMC Corporation (US) and Novozymes A/S (Denmark) are leading players in Biorational Pesticides Market

The biorational pesticides market is projected to grow from USD 7.5 billion in 2023 to USD 15.1 billion by 2028 growing at a CAGR of 15.2% during the forecast period. Increased recognition of the negative effects caused by synthetic chemical pesticides on ecosystems, biodiversity, and human health has led to a movement toward eco-friendly alternatives. Regulatory authorities are progressively advocating for biorational pesticides because of their reduced toxicity and lower environmental persistence in comparison to synthetic chemicals, thereby propelling the growth of the market.

For instance, as per the Ministry of Agriculture of Rural Affairs (MARA) website's 2021 data, China approved a total of 26 new active ingredients. Among these, 5 active ingredients were exclusively for export, while the majority of 21 new active ingredients were intended for domestic use and fell under the category of biopesticides. This trend might be attributed to the stringent criteria and comprehensive data prerequisites for registering new chemical pesticides. Numerous submissions for registration failed due to the necessity of providing toxicological information on metabolites, resulting in rejections. Conversely, the registration prerequisites for biopesticides involve comparatively lower data demands, leading to reduced uncertainties and a higher likelihood of obtaining registrations at an earlier stage.

To know about the assumptions considered for the study download the pdf brochure

The key players in the biorational pesticides market include BASF SE (Germany), Bayer AG (Germany), UPL (India), FMC Corporation (US), Syngenta AG (Switzerland), Novozymes A/S (Denmark), Sumitomo Chemical Co., Ltd (Japan), Pro Farm Group Inc (US), Koppert (Netherlands), Valent BioSciences LLC (US), Gowan Company (US), Certis Biologicals (US), Biobest Group (Belgium), BIONEMA (UK), and Vestaron Corporation (US). The key strategies the leading market players adopted include new product launches, mergers, partnerships, and expansions. For instance, In April 2023, Syngenta AG and Biotalys united in a strategic partnership to drive forward biological solutions for sustainable agriculture. This collaboration, announced jointly by Syngenta Crop Protection and Biotalys, signifies a combined effort to research, develop, and introduce novel biocontrol solutions that effectively combat significant pests across diverse crops. Their joint initiative revolves around harnessing Biotalys’ AGROBODY technology, a protein-based biocontrol solution, to pioneer an innovative approach. This envisioned solution aims to offer a unique mode of action, expanding the availability of cutting-edge technologies for farmers to counter the escalating threat posed by pest resistance. This partnership endeavors to advance sustainable agriculture by introducing pioneering strategies to tackle pest challenges.

FMC Corporation

In August 2023, FMC India, renowned for its advancements in agricultural sciences, unveiled its latest breakthrough product, ENTAZIATM biofungicide. This cutting-edge biological crop protection innovation is crafted with Bacillus subtilis, marking a significant stride in offering farmers a potent and sustainable solution to shield their crops from fungal threats without compromising environmental health. This groundbreaking product harnesses the natural capabilities of Bacillus subtilis to combat bacterial leaf blight, a severe disease affecting rice cultivation. By triggering the plant's defense mechanisms against pathogens, ENTAZIATM biofungicide effectively prevents and manages bacterial leaf blight while maintaining its non-toxicity to beneficial organisms like natural predators and parasites.

BASF SE

BASF SE is a prominent global chemical manufacturer and marketer, operating across six major business segments: chemicals, materials, industrial solutions, surface technologies, nutrition, and care, as well as agricultural solutions. Within the agricultural solutions segment, BASF SE offers a comprehensive portfolio of biological solutions for crop protection, seed treatment, turf and ornamentals, and urban and rural pest control. The crop protection segment focuses on providing foliar and drench-applied biological solutions to growers, assisting in pest and disease control while managing residues and resistance. This encompasses biorational pesticides. In October 2023, BASF SE announced a substantial investment, amounting to a high double-digit million euros, in constructing a new fermentation facility at its Ludwigshafen site. This state-of-the-art plant is set to produce biological and biotechnology-based crop protection products, catering to the needs of farmers with offerings such as biological fungicides and seed treatments.

Part of BASF's strategic plan involves utilizing this facility to manufacture the primary component of Inscalis, an innovative insecticide derived from a fungal strain. The commissioning of this plant is slated for the latter half of 2025 and is expected to create employment opportunities for around 30 individuals engaged in various roles encompassing production, logistics, engineering, and maintenance.

Novozymes A/S

Novozymes A/S is a global biotechnology company that focuses on producing and marketing enzymes, microorganisms, and biopharmaceutical ingredients. It operates through five segments: household care, food & beverages, bioenergy, processing, agriculture, and animal health & nutrition. Novozymes operates globally through its subsidiaries and partnerships with other companies. The major subsidiaries of the company are Novozymes Japan Ltd (Japan), Novozymes Biologicals Inc. (US), Novozymes Biologicals Limited (Canada), Novozymes Australia Pty Ltd (Australia), Novozymes South Asia Pvt. Ltd India), and Novozymes Spain S.A. (Spain). The operations are carried out in a number of countries around the world, including China, India, Brazil, Argentina, the UK, the US, and Canada.

In June 2022, Certis Biologicals and Novozymes A/S joined forces strategically to provide improved solutions for conventional row crop farmers. Their collaboration focused on advancing technologies to effectively control fungal diseases. The initiation of field trials aimed to assess the potential of combining Certis Biologicals’ innovative biofungicide active ingredient with newly registered Novozymes actives, aiming to boost effectiveness in combating fungal diseases.

Related Reports:

Biorational Pesticides Market by Source (Botanical, Microbial, Non-organic), Type (Biorational Insecticides, Biorational Fungicides, Biorational Nematicides, Biorational Herbicides), Mode of Application, Formulation and Region - Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]